PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Placental research may transform our understanding of autism and human brain evolution

Cambridge researcher Alex Tsompanidis studies how the placenta has shaped neurodevelopment throughout the history of our species

2025-09-16
(Press-News.org) CAMBRIDGE, England, UNITED KINGDOM, 9 September 2025 -- In a Genomic Press Interview published today in Brain Medicine, Dr. Alex Tsompanidis highlights an exciting new idea that positions the placenta at the center of human neurodevelopment and evolution, challenging conventional wisdom about the origins of autism and human cognition. The interview, part of Genomic Press's Innovators & Ideas series, captures a pivotal moment in neuroscience as researchers worldwide recognize pregnancy biology as fundamental to understanding brain diversity across all human populations.

Revolutionary Framework Reshapes Global Understanding

Dr. Tsompanidis, honored as one of Spectrum magazine's top 40 under 40 autism researchers and recipient of the International Society for Autism Research Best Dissertation Award, has emerged as a new influential voice in developmental neuroscience. His research transcends traditional boundaries between obstetrics and neurology, revealing how prenatal steroid hormones produced by the placenta may fundamentally influence brain architecture and contribute to human neurodiversity.

His recent hypothesis, published in Evolutionary Anthropology, proposes that placental hormone production played a crucial role in the evolution of human cognitive capabilities, an idea that could fundamentally reframe how scientists understand the origins of human intelligence.

The significance of this work extends beyond academic circles. By highlighting the placenta as an active orchestrator of neurodevelopment rather than a passive barrier, Dr. Tsompanidis and his international collaborators have opened unprecedented avenues for understanding neurodiversity that could benefit millions of families worldwide.

"The placenta holds translational potential, as it is readily available at birth," Dr. Tsompanidis explains in the interview. His vision encompasses screening protocols that could be implemented at birth and accelerate diagnosis and the offering of support for children with developmental differences.

From Athens Laboratory to International Research Consortia

The interview traces Dr. Tsompanidis's scientific journey from childhood microscopy experiments in Athens to leading research initiatives spanning three continents. His path illustrates how modern science transcends geographical boundaries, with formative experiences in Greece, the United States, Germany, and Taiwan shaping his multidisciplinary approach.

A defining moment came during his medical training in Athens when he encountered a seven-year-old autistic child who could not speak yet displayed remarkable curiosity about the world around him. The mother's distress at receiving limited information about autism's causes or her child's future prospects crystallized Dr. Tsompanidis's commitment to advancing scientific understanding. "I thought then that we ought to do better," he reflects, describing how this encounter redirected his career toward unraveling autism's biological foundations.

Placenta-Brain Axis Emerges as Scientific Frontier

His current research supported by the Simons Foundation explores mechanisms through which the placenta and hormones such as testosterone and estrogens shape developing neural circuits. As part of a team led by Professor Sir Simon Baron-Cohen (Cambridge), Dr. Tsompanidis and his international research collaborators have teamed up to study biological factors across multiple levels of biology, from genetic variants to molecular pathways, and from brain structure to behavioral outcomes. This comprehensive approach reveals how pregnancy complications and neurodevelopmental conditions share common biological threads, particularly regarding prenatal sex differences, which may be particularly relevant in understanding the origins of autism; a condition that affects, on average, more males than females.

The evolutionary dimension of his work adds a new perspective, showing that adaptations in placental function may have enabled the development of humanity's uniquely large and interconnected brains in the first place. This intriguing hypothesis links placental hormones to the emergence of complex cognition, language, and social behaviors that define our species. The implications extend to understanding why certain neurodevelopmental patterns persist across human populations despite varying environmental and cultural contexts.

His research philosophy emphasizes hypothesis-driven investigation combined with multidisciplinary perspectives. By connecting insights from obstetrics, evolutionary biology, and neuroscience, Dr. Tsompanidis exemplifies how crossing traditional academic boundaries generates transformative understanding. This approach has proven particularly valuable in recognizing patterns that single-discipline studies might overlook.

Advancing Inclusive Science and Global Collaboration

Beyond his research contributions, Dr. Tsompanidis advocates for greater inclusion in scientific endeavors, particularly highlighting barriers faced by international students and the urgent need for expanded research into women's health conditions. He emphasizes how conditions such as endometriosis and polycystic ovary syndrome remain poorly understood despite affecting millions worldwide, calling for concerted efforts to empower researchers of all genders  and backgrounds to investigate these critical health challenges.

His commitment to mentoring reflects personal experience navigating international research environments. "Science is always collaborative," he notes, crediting mentors who supported his journey while encouraging current students to pursue opportunities boldly. This perspective shapes the culture at the Autism Research Centre of the University of Cambridge, where he supervises students from various nations pursuing questions at the intersection of neurodevelopment and human evolution.

The interview reveals Dr. Tsompanidis's broader vision for autism research that transcends medical models dividing health from pathology. He advocates for understanding autism as part of human neurodiversity's natural spectrum, requiring collaboration with autistic communities to integrate lived experiences with clinical and basic research findings. This inclusive approach ensures research priorities align with community needs while advancing scientific understanding.

Dr. Alex Tsompanidis's Genomic Press interview is part of a larger series called Innovators & Ideas that highlights the people behind today's most influential scientific breakthroughs. Each interview in the series offers a blend of cutting-edge research and personal reflections, providing readers with a comprehensive view of the scientists shaping the future. By combining a focus on professional achievements with personal insights, this interview style invites a richer narrative that both engages and educates readers. This format provides an ideal starting point for profiles that explore the scientist's impact on the field, while also touching on broader human themes. More information on the research leaders and rising stars featured in our Innovators & Ideas -- Genomic Press Interview series can be found on our publications website: https://genomicpress.kglmeridian.com/.

The Genomic Press Interview in Brain Medicine titled "Alex Tsompanidis: Understanding the role of the placenta in human neurodevelopment," is freely available via Open Access on 9 September 2025 in Brain Medicine at the following hyperlink: https://doi.org/10.61373/bm025k.0110.

About Brain Medicine: Brain Medicine (ISSN: 2997-2639, online and 2997-2647, print) is a peer-reviewed medical research journal published by Genomic Press, New York. Brain Medicine is a new home for the cross-disciplinary pathway from innovation in fundamental neuroscience to translational initiatives in brain medicine. The journal's scope includes the underlying science, causes, outcomes, treatments, and societal impact of brain disorders, across all clinical disciplines and their interface.

Visit the Genomic Press Virtual Library: https://issues.genomicpress.com/bookcase/gtvov/

Our full website is at: https://genomicpress.kglmeridian.com/

END


ELSE PRESS RELEASES FROM THIS DATE:

Mapping the Universe, faster and with the same accuracy

2025-09-16
If you think a galaxy is big, compare it to the size of the Universe: it’s just a tiny dot which, together with a huge number of other tiny dots, forms clusters that aggregate into superclusters, which in turn weave into filaments threaded with voids—an immense 3D skeleton of our Universe. If that gives you vertigo and you’re wondering how one can understand or even “see” something so vast, the answer is: it isn’t easy. Scientists combine the physics of the Universe with data from astronomical instruments and build theoretical models, such as EFTofLSS (Effective Field Theory of Large-Scale Structure). ...

Study isolates population aging as primary driver of musculoskeletal disorders

2025-09-16
Philadelphia, September 16, 2025 – Novel research shows that in approximately one third of countries and territories worldwide, population aging was the largest contributor to the growing burden of musculoskeletal disorders from 1990 to 2021. The new study in the Annals of the Rheumatic Diseases, published by Elsevier, is poised to inform targeted public health strategies and healthcare resource allocation to alleviate the global burden and economic impact of these disorders. Musculoskeletal disorders—conditions ...

Designing a sulfur vacancy redox disruptor for photothermoelectric and cascade‑catalytic‑driven cuproptosis–ferroptosis–apoptosis therapy

2025-09-16
As cancer evolves, the demand for intelligent therapeutics that integrate energy conversion, metabolic interference, and immune activation intensifies. Now, researchers from Harbin Engineering University and Harbin Normal University, led by Professor Piaoping Yang, Professor Lili Feng, and Professor Wei Guo, have delivered a comprehensive study on biodegradable Cu2MnS3-x-PEG/glucose oxidase (MCPG) nanosheets that realize triple-modal cell death. This work offers a blueprint for next-generation nanotherapies that break the “resistance ceiling” of single-mechanism treatments. Why MCPG Matters Energy Conversion: MCPG harvests 1064 nm NIR-II photons, ...

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

2025-09-16
In August 2017, the National Natural Science Foundation of China (NSFC) launched the Major Research Plan “Dynamic Modifications and Chemical Interventions of Biomacromolecules” (implementation period 2017–2025). Through interdisciplinary research that integrates chemistry, life sciences, medicine, mathematics, materials science, and information science, its aim is to develop specific labeling methods and detection techniques for dynamic chemical modifications of biomacromolecules, elucidate the recognition mechanisms and biological functions of dynamic ...

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

2025-09-16
NEW YORK AND NAPLES, FL – September 15, 2025 – The Cardiovascular Research Foundation® (CRF®) and Jon DeHaan Foundation today announced the launch of the TCT AI Lab, a groundbreaking new program debuting at TCT® 2025, October 25–28 at the Moscone Center in San Francisco. The TCT AI Lab is a first-of-its-kind destination dedicated to integrating artificial intelligence into clinical practice. Over three intensive days, clinicians will progress from the fundamentals of AI to hands-on clinical applications – guided by leading innovators ...

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

2025-09-15
Simon Fraser University’s Burnaby campus is once again home to Canada’s most powerful academic supercomputer, following the installation of a new system, named Fir. The new Fir system replaces the Cedar supercomputer, housed at the Cedar Supercomputing Centre (the Centre) at SFU. Fir is ranked number 78 in the TOP500 list of the world’s most powerful supercomputers, the only Canadian system in the top 100 worldwide. “The new Fir supercomputer represents a much needed, major upgrade to the national Canadian computing infrastructure,” says ...

Architecture’s past holds the key to sustainable future

2025-09-15
Modern ‘sustainable’ innovations in architecture are failing to slow climate change,  but revisiting ancient knowledge and techniques found in traditional architecture could offer better solutions. This is the argument of architectural historians Professor Florian Urban and Barnabas Calder in their new book Form Follows Fuel: 14 Buildings from Antiquity to the Oil Age. The authors argue that energy availability has been the biggest influence in architecture throughout human history. Their extensive ...

Laser correction for short-sightedness is safe and effective for older teenagers

2025-09-15
Copenhagen, Denmark: A major study of laser correction for short-sightedness shows that the procedure is as safe and effective in older teenagers as it is in adults, according to research presented today (Tuesday) at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). [1]   Short-sightedness, or myopia, affects around a third of children and teenagers and research suggests that it is becoming more common.   A laser treatment, called photorefractive keratectomy (PRK), is widely used to treat myopia in adults but questions remain over its use in teenagers.   The new study was presented by Dr Avinoam Shye, from the Department of Ophthalmology ...

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

2025-09-15
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) shows that some individuals who are taking Ozempic, Wegovy or Mounjaro find that foods taste sweeter or saltier than before. About one in five of those participating in the real-word study, published in the journal Diabetes, Obesity and Metabolism, perceived sweetness more intensely and a similar number were more sensitive to salt – and these changes were linked to a reduction in appetite. “Incretin-based therapies such as Ozempic, Wegovy and Mounjaro are widely used for weight management ...

Taking semaglutide turns down food noise, research suggests

2025-09-15
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) shows that individuals who are taking semaglutide for weight loss experience less food noise than before. Food noise refers to obsessive and intrusive thoughts about food and eating.  This preoccupation with food can hinder healthy lifestyle implementation and lead to overeating, making weight loss difficult. Previous research has found that 57% of people who have living ...

LAST 30 PRESS RELEASES:

Placental research may transform our understanding of autism and human brain evolution

Mapping the Universe, faster and with the same accuracy

Study isolates population aging as primary driver of musculoskeletal disorders

Designing a sulfur vacancy redox disruptor for photothermoelectric and cascade‑catalytic‑driven cuproptosis–ferroptosis–apoptosis therapy

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

Taking semaglutide turns down food noise, research suggests

Type 2 diabetes may double risk of sepsis, large community-based study suggests

New quantum sensors can withstand extreme pressure

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

How NIL boosts college football’s competitive balance

Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients

Construction secrets of honeybees: Study reveals how bees build hives in tricky spots

Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021

New funding fuels development of first potentially regenerative treatment for multiple sclerosis

NJIT student–faculty team wins best presentation award for ant swarm simulation

Ants defend plants from herbivores but can hinder pollination

When the wireless data runs dry

Inquiry into the history of science shows an early “inherence” bias

Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores

Study suggests most Americans would be healthier without daylight saving time

Increasing the level of the protein PI31 demonstrates neuroprotective effects in mice

Multi-energy X-ray curved surface imaging-with multi-layer in-situ grown scintillators

Metasurface enables compact and high-sensitivity atomic magnetometer

[Press-News.org] Placental research may transform our understanding of autism and human brain evolution
Cambridge researcher Alex Tsompanidis studies how the placenta has shaped neurodevelopment throughout the history of our species